Renal-Cell Carcinoma | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Kidney cancer is one of the 10 most common cancers in the United States with 90% being
attributed to renal cell carcinoma. Men, especially black men, are more likely to be affected …

The incidence of renal cell carcinoma (RCC) is increasing. Despite improvements in the
management of localized RCC, most patients are diagnosed with advanced RCC, which is …

Approximately one-third of patients with RCC3 have metastatic disease at initial
presentation or on relapse, and the prognosis for metastatic RCC remains highly …

Renal-cell carcinoma is among the most resistant of tumors to therapy. Until 2005, only a
single treatment, high-dose interleukin-2, had been approved by the Food and Drug …

Although renal cell carcinoma accounts for only 3% of adult malignancies, it has been
increasing in incidence by 2–4% per year since the 1970's. Cigarette smoking, obesity and …

Renal cell carcinoma (RCC) accounts for 2%–3% of all adult malignancies, representing the
seventh most common cancer in men and the ninth most common cancer in women [1] …

Renal cell carcinoma continues to be a difficult malignancy to treat because of its ability to
spread asymptomatically and its inherent resistance to conventional chemotherapy …

Purpose: Our understanding of the natural history of renal cell carcinoma, the role of
nephrectomy, the benefits of immunotherapy and the possibilities of new technologies are …

Renal cell carcinoma (RCC) is characterized by (a) lack of early warning signs, which results
in a high proportion of patients with metastases at the time of diagnosis;(b) protean clinical …